Cargando…

342. Secondary Infections following Tocilizumab for Treatment of COVID-19 Pneumonia

BACKGROUND: Guidelines recommend use of tocilizumab (TCZ), an inhibitor of pro-inflammatory IL-6 signaling, for hospitalized patients with progressive severe or critical Coronavirus disease 2019 (COVID-19). The incidence of infectious complications following the use of TCZ for COVID-19 has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warner, Adam, Abbas, Mujahed, Avner, Benjamin S, Flynn, Thomas E, Walroth, Todd A, Jagger, Brett W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690531/ http://dx.doi.org/10.1093/ofid/ofab466.543

Ejemplares similares

563. Tocilizumab in the Treatment of Critical COVID-19 Pneumonia
por: Fisher, Matthew, et al.
Publicado: (2020)

400. Secondary Infections in COVID-19 Patients Receiving Tocilizumab in a Community Hospital
por: Usiak, Shauna, et al.
Publicado: (2020)

342. Clinical Utility of a Next Generation Sequencing Test for Pathogen Detection in Pediatric Central Nervous System Infections
por: Ramchandar, Nanda, et al.
Publicado: (2020)

34.2 IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN SECONDARY MENTAL HEALTH CARE
por: Fusar-poli, Paolo, et al.
Publicado: (2018)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

550. Clinical impact of Tocilizumab therapy in SARS-CoV-2 respiratory infections in ICU and non-ICU patients
por: Vyas, Nikunj M, et al.
Publicado: (2020)

562. Tocilizumab Use in the Second Trimester Pregnant Patients with Severe Covid-19 Pneumonia and their Maternal and Fetal Outcomes: Two Case Reports
por: iqbal, Fatima, et al.
Publicado: (2021)

Tocilizumab: Secondary organising pneumonia: case report
Publicado: (2022)

566. Tocilizumab: A Friend or a Foe in COVID-19 Management?
por: Hernandez, Jarelys M, et al.
Publicado: (2020)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

564. Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19
por: Colgrove, Robert, et al.
Publicado: (2020)

565. Tocilizumab Use in COVID-19: Act(emra) to Inhibit Intubation and Decompensation
por: Willner, Debra M, et al.
Publicado: (2020)

P342: Patient safety and risk management in health center in Niger
por: Djibo, H, et al.
Publicado: (2013)

P342: RAS PATHWAY ACTIVATION REMODELS THE BONE MARROW MICROENVIRONMENT IN ACUTE LYMPHOBLASTIC LEUKAEMIA
por: Ferrao Blanco, Mauricio, et al.
Publicado: (2023)

49. Clinical Characteristics of the 2019 Eastern Equine Encephalitis Virus Outbreak in Michigan
por: Ladzinski, Adam T, et al.
Publicado: (2020)

297. Infectious Complications Associated with Tocilizumab Use in Patients Infected with SARS-CoV-2 at a Mid-Atlantic Hospital Consortium
por: Kent, Kristen R, et al.
Publicado: (2021)

304. Impact of Antibiotic Prophylaxis Prior to Treatment with Steroids and Tocilizumab in COVID-19 Patients
por: de Novales, Francisco Javier Membrillo, et al.
Publicado: (2021)

554. Early Clinical Outcomes with Tocilizumab for Covid-19: A Two-Center Retrospective Study
por: Smoke, Steven, et al.
Publicado: (2020)

562. Tocilizumab for the Treatment of Severe COVID-19: A Retrospective, Multi-Center, Case-Matched Series
por: Norman, Sarah, et al.
Publicado: (2020)

539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2
por: Rosati, Michael, et al.
Publicado: (2021)

341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab
por: Barsoum, Barbara, et al.
Publicado: (2021)

TME2/342: The Role of the EXtensible Markup Language (XML) for Future Healthcare Application Development
por: Noelle, G, et al.
Publicado: (1999)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER
por: Macatangay, M.V.R., et al.
Publicado: (2022)

308. Secondary Infections in Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 Pneumonia (PNA)
por: Rivosecchi, Ryan, et al.
Publicado: (2021)

342. Evaluation of Patient Satisfaction with Outpatient Parenteral Antibiotic Therapy (OPAT) at a University Medical Center
por: Sawey, Ciara, et al.
Publicado: (2023)

Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya
por: Shah, Reena, et al.
Publicado: (2022)

P1413: DOES TOCILIZUMAB INCREASE THE RISK OF INFECTIONS IN PATIENTS UNDERGOING CAR-T THERAPY?
por: Greenhalgh, Sophie, et al.
Publicado: (2023)

123. Utilization of the BioFire® FilmArray® Pneumonia Panel in Critically Ill Patients with Influenza Pneumonia
por: Ereshefsky, Benjamin, et al.
Publicado: (2020)

1304. Antimicrobial Management of Stenotrophomonas maltophilia Pneumonia: Does TMP-SMX Dose Affect Treatment Failure?
por: Keck, J Myles, et al.
Publicado: (2021)

MED2/342: The Role of the Internet in the Education of Health Information Managers in Courses in the USA, Australia, Germany and China
por: Lange, A
Publicado: (1999)

342. Time to Antimicrobial De-escalation/Discontinuation After Implementation of Cerebrospinal Fluid Polymerase Chain Reaction Tool
por: Chicoineau, Michelle, et al.
Publicado: (2018)

301. Detection of Pneumococcal Pneumonia During SARS-CoV-2 Infection
por: Watkins, Anne, et al.
Publicado: (2021)

534. The Use of Tocilizumab and Remdesivir in SARS- CoV-2 Patients in El Paso Texas: A Longitudinal Comparative Observational Study
por: Almaghlouth, Nouf K, et al.
Publicado: (2021)

310. Cryptococcal Infection Following COVID-19 infection in Solid Organ Transplant Recipients: A Case Series
por: Walker, Jeremey, et al.
Publicado: (2021)

682. Is There a Role for the Early Use of Tocilizumab and Interleukin-6 Levels in the Management of SARS-CoV-2 Patients with Early Respiratory Failure?
por: Antony, Suresh J, et al.
Publicado: (2020)

Health Tract No. 342: Lunacy
Publicado: (1868)

PM342. Treatment effect of Methylphenidate on Functional Brain Network in children with ADHD: findings from multivariate pattern analysis
por: Yoo, Jae Hyun, et al.
Publicado: (2016)

342. The Impact of Glycemic Control on CD4 Cell Count in Persons Living with HIV and Diabetes Mellitus—Washington, DC
por: Powers Happ, Lindsey J, et al.
Publicado: (2019)

367. Clinical Characteristics and Outcomes in Patients with Pneumonia secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Nichols, Courtney, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d093pragkjp5sjuh86mpkim7gv